On track to tackle dengue: History and future of NS4B ligands

A recent publication in Nature (Kaptein et al., 2021) reports a highly potent antiviral compound against dengue with promising efficacy in mice. Here, we track the history of this compound class, its pharmacology, and its chemistry, with insights into its potential as orally available drugs to preve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Behnam, Mira A. M. (VerfasserIn) , Klein, Christian D. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 December 2021
In: Cell host and microbe
Year: 2021, Jahrgang: 29, Heft: 12, Pages: 1735-1737
ISSN:1934-6069
DOI:10.1016/j.chom.2021.11.010
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.chom.2021.11.010
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1931312821005163
Volltext
Verfasserangaben:Mira A.M. Behnam, Christian D. Klein
Beschreibung
Zusammenfassung:A recent publication in Nature (Kaptein et al., 2021) reports a highly potent antiviral compound against dengue with promising efficacy in mice. Here, we track the history of this compound class, its pharmacology, and its chemistry, with insights into its potential as orally available drugs to prevent and treat dengue.
Beschreibung:Gesehen am 15.02.2022
Beschreibung:Online Resource
ISSN:1934-6069
DOI:10.1016/j.chom.2021.11.010